Click here to get full coverage on 'Lupin' Season 4 to Release in October on Netflix - The Hollywood Reporter

'Lupin' Season 4 to Release in October on Netflix  The Hollywood Reporter

'Lupin' Season 4 to Release in October on Netflix - The Hollywood Reporter

Click here to get full coverage on Netflix Unveils ‘Lupin’ Part 4 2026 Premiere Date and Poster - Deadline

Netflix Unveils ‘Lupin’ Part 4 2026 Premiere Date and Poster  Deadline

Netflix Unveils ‘Lupin’ Part 4 2026 Premiere Date and Poster - Deadline

Click here to get full coverage on Lupin Launches Azilsartan Medoxomil Tablets in the United States - PR Newswire

Lupin Launches Azilsartan Medoxomil Tablets in the United States  PR Newswire

Lupin Launches Azilsartan Medoxomil Tablets in the United States - PR Newswire

Click here to get full coverage on Otsuka Pharmaceutical Co. v. Lupin Ltd. (Fed. Cir. 2026) - JD Supra

Otsuka Pharmaceutical Co. v. Lupin Ltd. (Fed. Cir. 2026)  JD Supra

Otsuka Pharmaceutical Co. v. Lupin Ltd. (Fed. Cir. 2026) - JD Supra

Click here to get full coverage on Lupin Part 4 Will Arrive October 23 - Netflix

Lupin Part 4 Will Arrive October 23  Netflix

Lupin Part 4 Will Arrive October 23 - Netflix

Click here to get full coverage on Netflix’s ‘Lupin’ Part 4 Sets October Release Date (TV News Roundup) - Variety

Netflix’s ‘Lupin’ Part 4 Sets October Release Date (TV News Roundup)  Variety

Netflix’s ‘Lupin’ Part 4 Sets October Release Date (TV News Roundup) - Variety

Click here to get full coverage on ‘Lupin’ Announces Part 4 Release Date - Frenchly

‘Lupin’ Announces Part 4 Release Date  Frenchly

‘Lupin’ Announces Part 4 Release Date - Frenchly

Click here to get full coverage on Lupin Lodge, Iconic Silicon Valley Nude Resort, Listed for $32.8M - TravelWires

Lupin Lodge, Iconic Silicon Valley Nude Resort, Listed for $32.8M  TravelWires

Lupin Lodge, Iconic Silicon Valley Nude Resort, Listed for $32.8M - TravelWires

Click here to get full coverage on FDA approves Lupin's Lucentis biosimilar injection - Eyes On Eyecare

FDA approves Lupin's Lucentis biosimilar injection  Eyes On Eyecare

FDA approves Lupin's Lucentis biosimilar injection - Eyes On Eyecare

Click here to get full coverage on Lupin III: The Castle of Cagliostro (1979) - IMDb

Lupin III: The Castle of Cagliostro (1979)  IMDb

Lupin III: The Castle of Cagliostro (1979) - IMDb

Click here to get full coverage on Netflix Confirms ‘Lupin’ Part 4 Release Date for October 2026 - What's on Netflix

Netflix Confirms ‘Lupin’ Part 4 Release Date for October 2026  What's on Netflix

Netflix Confirms ‘Lupin’ Part 4 Release Date for October 2026 - What's on Netflix

Click here to get full coverage on Lupin Completes Acquisition of VISUfarma - PR Newswire

Lupin Completes Acquisition of VISUfarma  PR Newswire

Lupin Completes Acquisition of VISUfarma - PR Newswire

Click here to get full coverage on Lupin Receives U.S. FDA Approval for Famotidine Injection, USP - PR Newswire

Lupin Receives U.S. FDA Approval for Famotidine Injection, USP  PR Newswire

Lupin Receives U.S. FDA Approval for Famotidine Injection, USP - PR Newswire

Click here to get full coverage on Lupin Receives U.S. FDA Approval for Glycerol Phenylbutyrate Oral Liquid - PR Newswire

Lupin Receives U.S. FDA Approval for Glycerol Phenylbutyrate Oral Liquid  PR Newswire

Lupin Receives U.S. FDA Approval for Glycerol Phenylbutyrate Oral Liquid - PR Newswire

Click here to get full coverage on Lupin Receives Approval from U.S. FDA for Ranluspec™(ranibizumab) Injection - PR Newswire

Lupin Receives Approval from U.S. FDA for Ranluspec™(ranibizumab) Injection  PR Newswire

Lupin Receives Approval from U.S. FDA for Ranluspec™(ranibizumab) Injection - PR Newswire

Click here to get full coverage on Lupin Receives China Approval for Oseltamivir Phosphate Oral Suspension - PR Newswire

Lupin Receives China Approval for Oseltamivir Phosphate Oral Suspension  PR Newswire

Lupin Receives China Approval for Oseltamivir Phosphate Oral Suspension - PR Newswire

Click here to get full coverage on Lupin Launches Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets in the United States - PR Newswire

Lupin Launches Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets in the United States  PR Newswire

Lupin Launches Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets in the United States - PR Newswire

Click here to get full coverage on Lupin Shares Phase 1 Data on LNP8701 at the ASCO Annual Meeting 2026 - PR Newswire

Lupin Shares Phase 1 Data on LNP8701 at the ASCO Annual Meeting 2026  PR Newswire

Lupin Shares Phase 1 Data on LNP8701 at the ASCO Annual Meeting 2026 - PR Newswire

Click here to get full coverage on Save The Dates: Adults Season 2, Lupin Part 4 On Netflix, And More - TVLine

Save The Dates: Adults Season 2, Lupin Part 4 On Netflix, And More  TVLine

Save The Dates: Adults Season 2, Lupin Part 4 On Netflix, And More - TVLine

Click here to get full coverage on Lupin Receives Tentative Approval from U.S. FDA for Pitolisant Tablets - PR Newswire

Lupin Receives Tentative Approval from U.S. FDA for Pitolisant Tablets  PR Newswire

Lupin Receives Tentative Approval from U.S. FDA for Pitolisant Tablets - PR Newswire

Click here to get full coverage on Lupin Announces New U.S. Manufacturing Facility and $250 Million Domestic Investment - Association for Accessible Medicines

Lupin Announces New U.S. Manufacturing Facility and $250 Million Domestic Investment  Association for Accessible Medicines

Lupin Announces New U.S. Manufacturing Facility and $250 Million Domestic Investment - Association for Accessible Medicines

Click here to get full coverage on FDA Approves Lupin’s Interchangeable Ranibizumab Biosimilar Ranluspec for Multiple Retinal Diseases - BioPharm International

FDA Approves Lupin’s Interchangeable Ranibizumab Biosimilar Ranluspec for Multiple Retinal Diseases  BioPharm International

FDA Approves Lupin’s Interchangeable Ranibizumab Biosimilar Ranluspec for Multiple Retinal Diseases - BioPharm International

Click here to get full coverage on Lovely lupins: Enjoy these photos from around New Brunswick - CBC

Lovely lupins: Enjoy these photos from around New Brunswick  CBC

Lovely lupins: Enjoy these photos from around New Brunswick - CBC

Click here to get full coverage on Lupin Announces the Approval of Dapagliflozin Tablets in the United States - PR Newswire

Lupin Announces the Approval of Dapagliflozin Tablets in the United States  PR Newswire

Lupin Announces the Approval of Dapagliflozin Tablets in the United States - PR Newswire

Click here to get full coverage on Lupin Launches Dasatinib Tablets in the United States - PR Newswire

Lupin Launches Dasatinib Tablets in the United States  PR Newswire

Lupin Launches Dasatinib Tablets in the United States - PR Newswire

Click here to get full coverage on Lupin Launches Risperidone Long-Acting Injectable with 180-day CGT exclusivity in the U.S., the First Product from its Proprietary Long-Acting Injectable Platform PrecisionSphere™ - PR Newswire

Lupin Launches Risperidone Long-Acting Injectable with 180-day CGT exclusivity in the U.S., the First Product from its Proprietary Long-Acting Injectable Platform PrecisionSphere™  PR Newswire

Lupin Launches Risperidone Long-Acting Injectable with 180-day CGT exclusivity in the U.S., the First Product from its Proprietary Long-Acting Injectable Platform PrecisionSphere™ - PR Newswire

Click here to get full coverage on Lupin Receives Approval from U.S. FDA for Sodium Sulfate, Magnesium Sulfate, and Potassium Chloride Tablets - PR Newswire

Lupin Receives Approval from U.S. FDA for Sodium Sulfate, Magnesium Sulfate, and Potassium Chloride Tablets  PR Newswire

Lupin Receives Approval from U.S. FDA for Sodium Sulfate, Magnesium Sulfate, and Potassium Chloride Tablets - PR Newswire

Click here to get full coverage on Netflix Unveils Premiere Date for Top 10 Thriller With 98% Rotten Tomatoes Score - Men's Journal

Netflix Unveils Premiere Date for Top 10 Thriller With 98% Rotten Tomatoes Score  Men's Journal

Netflix Unveils Premiere Date for Top 10 Thriller With 98% Rotten Tomatoes Score - Men's Journal

Click here to get full coverage on 'Lupin Part 4' Slated to Return on Netflix - Hypebeast

'Lupin Part 4' Slated to Return on Netflix  Hypebeast

'Lupin Part 4' Slated to Return on Netflix - Hypebeast

Click here to get full coverage on Lupin Receives Tentative Approval from U.S. FDA for Sugammadex Injection - PR Newswire

Lupin Receives Tentative Approval from U.S. FDA for Sugammadex Injection  PR Newswire

Lupin Receives Tentative Approval from U.S. FDA for Sugammadex Injection - PR Newswire

Click here to get full coverage on Vinita Gupta on Leading Lupin - Naples Illustrated

Vinita Gupta on Leading Lupin  Naples Illustrated

Vinita Gupta on Leading Lupin - Naples Illustrated

Click here to get full coverage on Vinita Gupta, Lupin CEO, Named to the 2026 CNBC Changemakers List of Women Transforming Business for Making Medicines Accessible and Affordable for Americans - PR Newswire

Vinita Gupta, Lupin CEO, Named to the 2026 CNBC Changemakers List of Women Transforming Business for Making Medicines Accessible and Affordable for Americans  PR Newswire

Vinita Gupta, Lupin CEO, Named to the 2026 CNBC Changemakers List of Women Transforming Business for Making Medicines Accessible and Affordable for Americans - PR Newswire

Click here to get full coverage on Lupin and Natco Receive Approval from U.S. FDA for Eribulin Mesylate Injection - Yahoo Finance

Lupin and Natco Receive Approval from U.S. FDA for Eribulin Mesylate Injection  Yahoo Finance

Lupin and Natco Receive Approval from U.S. FDA for Eribulin Mesylate Injection - Yahoo Finance

Click here to get full coverage on Lupin bets big on India's GLP-1 market & respiratory drugs - CNBC

Lupin bets big on India's GLP-1 market & respiratory drugs  CNBC

Lupin bets big on India's GLP-1 market & respiratory drugs - CNBC

Click here to get full coverage on Lupin Launches Continue To Multiply - Citeline News & Insights

Lupin Launches Continue To Multiply  Citeline News & Insights

Lupin Launches Continue To Multiply - Citeline News & Insights

Click here to get full coverage on Netflix’s ‘Lupin’ Part 4 Sets October Release Date (TV News Roundup) - Yahoo

Netflix’s ‘Lupin’ Part 4 Sets October Release Date (TV News Roundup)  Yahoo

Netflix’s ‘Lupin’ Part 4 Sets October Release Date (TV News Roundup) - Yahoo

Click here to get full coverage on India's Lupin settles US patent dispute with Astellas Pharma for $90 million - Reuters

India's Lupin settles US patent dispute with Astellas Pharma for $90 million  Reuters

India's Lupin settles US patent dispute with Astellas Pharma for $90 million - Reuters

Click here to get full coverage on Lupin Strengthens its Global Specialty Ophthalmology Business with Acquisition of VISUfarma from GHO Capital - PR Newswire

Lupin Strengthens its Global Specialty Ophthalmology Business with Acquisition of VISUfarma from GHO Capital  PR Newswire

Lupin Strengthens its Global Specialty Ophthalmology Business with Acquisition of VISUfarma from GHO Capital - PR Newswire

Click here to get full coverage on Lupin Announces Plans to Build a New State-of-the-Art Manufacturing Facility in Coral Springs, Florida Extending its Long-Standing Commitment to America's Patients and Healthcare System - PR Newswire

Lupin Announces Plans to Build a New State-of-the-Art Manufacturing Facility in Coral Springs, Florida Extending its Long-Standing Commitment to America's Patients and Healthcare System  PR Newswire

Lupin Announces Plans to Build a New State-of-the-Art Manufacturing Facility in Coral Springs, Florida Extending its Long-Standing Commitment to America's Patients and Healthcare System - PR Newswire

Click here to get full coverage on Netflix Officially Announces Return Date for Near-Perfect Mystery Thriller Series - MovieWeb

Netflix Officially Announces Return Date for Near-Perfect Mystery Thriller Series  MovieWeb

Netflix Officially Announces Return Date for Near-Perfect Mystery Thriller Series - MovieWeb

Click here to get full coverage on India's Zydus, Lupin sign deal to co‑market Semaglutide injections - Reuters

India's Zydus, Lupin sign deal to co‑market Semaglutide injections  Reuters

India's Zydus, Lupin sign deal to co‑market Semaglutide injections - Reuters

Click here to get full coverage on Netflix reveals Lupin part 4 premiere date - The Killing Times

Netflix reveals Lupin part 4 premiere date  The Killing Times

Netflix reveals Lupin part 4 premiere date - The Killing Times

Click here to get full coverage on Lupin rides the onshoring wave, pledging $250M to build new respiratory production plant in Fla. - Fierce Pharma

Lupin rides the onshoring wave, pledging $250M to build new respiratory production plant in Fla.  Fierce Pharma

Lupin rides the onshoring wave, pledging $250M to build new respiratory production plant in Fla. - Fierce Pharma

Click here to get full coverage on Differences in metabolic profiles of lupin-based beverages produced with various fermentation techniques - Nature

Differences in metabolic profiles of lupin-based beverages produced with various fermentation techniques  Nature

Differences in metabolic profiles of lupin-based beverages produced with various fermentation techniques - Nature

Click here to get full coverage on Lupin settles Myrbetriq patent spat with Astellas for $90m - pharmaphorum

Lupin settles Myrbetriq patent spat with Astellas for $90m  pharmaphorum

Lupin settles Myrbetriq patent spat with Astellas for $90m - pharmaphorum

Click here to get full coverage on Lupin FY2026 and Q4 FY2026 Results - Lupin | Press Release - lupin.com

Lupin FY2026 and Q4 FY2026 Results - Lupin | Press Release  lupin.com

Lupin FY2026 and Q4 FY2026 Results - Lupin | Press Release - lupin.com

Click here to get full coverage on ‘Lupin’ Part 4 Sets Fall 2026 Release on Netflix - Variety

‘Lupin’ Part 4 Sets Fall 2026 Release on Netflix  Variety

‘Lupin’ Part 4 Sets Fall 2026 Release on Netflix - Variety

Click here to get full coverage on Lupin and Sandoz sign licensing deal for biosimilar ranibizumab across multiple regions - Ophthalmology Times

Lupin and Sandoz sign licensing deal for biosimilar ranibizumab across multiple regions  Ophthalmology Times

Lupin and Sandoz sign licensing deal for biosimilar ranibizumab across multiple regions - Ophthalmology Times

Click here to get full coverage on Lupin Launches Risperidone Long-Acting Injectable with 180-day CGT exclusivity in the U.S., the First Product from its Proprietary Long-Acting Injectable Platform PrecisionSphere™ - Lupin | Press Release - lupin.com

Lupin Launches Risperidone Long-Acting Injectable with 180-day CGT exclusivity in the U.S., the First Product from its Proprietary Long-Acting Injectable Platform PrecisionSphere™ - Lupin | Press Release  lupin.com

Lupin Launches Risperidone Long-Acting Injectable with 180-day CGT exclusivity in the U.S., the First Product from its Proprietary Long-Acting Injectable Platform PrecisionSphere™ - Lupin | Press Release - lupin.com

Click here to get full coverage on Zydus follows Lupin with Myrbetriq settlement deal - pharmaphorum

Zydus follows Lupin with Myrbetriq settlement deal  pharmaphorum

Zydus follows Lupin with Myrbetriq settlement deal - pharmaphorum

Click here to get full coverage on ‘Harry Potter’ Audiobook: Iwan Rheon and Blake Harrison on Finding Lupin’s Werewolf Howl, Pettigrew’s Mouse Voice and Almost Playing Dobby - Variety

‘Harry Potter’ Audiobook: Iwan Rheon and Blake Harrison on Finding Lupin’s Werewolf Howl, Pettigrew’s Mouse Voice and Almost Playing Dobby  Variety

‘Harry Potter’ Audiobook: Iwan Rheon and Blake Harrison on Finding Lupin’s Werewolf Howl, Pettigrew’s Mouse Voice and Almost Playing Dobby - Variety

Click here to get full coverage on Lupin Receives U.S. FDA Approval for Risperidone Long-Acting Injectable, with 180-Day CGT Exclusivity, the First Product from its Nanomi's Long-Acting Injectable Platform - PR Newswire

Lupin Receives U.S. FDA Approval for Risperidone Long-Acting Injectable, with 180-Day CGT Exclusivity, the First Product from its Nanomi's Long-Acting Injectable Platform  PR Newswire

Lupin Receives U.S. FDA Approval for Risperidone Long-Acting Injectable, with 180-Day CGT Exclusivity, the First Product from its Nanomi's Long-Acting Injectable Platform - PR Newswire

Click here to get full coverage on Lupin Makes its Debut in Dow Jones Best-in-Class Indices 2026 - Lupin | Press Release - lupin.com

Lupin Makes its Debut in Dow Jones Best-in-Class Indices 2026 - Lupin | Press Release  lupin.com

Lupin Makes its Debut in Dow Jones Best-in-Class Indices 2026 - Lupin | Press Release - lupin.com

Click here to get full coverage on Lupin Subsidiary Reaches $30 Million Settlement With Humana While Denying Allegations - PYMNTS.com

Lupin Subsidiary Reaches $30 Million Settlement With Humana While Denying Allegations  PYMNTS.com

Lupin Subsidiary Reaches $30 Million Settlement With Humana While Denying Allegations - PYMNTS.com

Click here to get full coverage on Lupin, TPG Capital & EQT in talks to acquire Vitabiotics in £1bn takeover - Nutraceutical Business Review

Lupin, TPG Capital & EQT in talks to acquire Vitabiotics in £1bn takeover  Nutraceutical Business Review

Lupin, TPG Capital & EQT in talks to acquire Vitabiotics in £1bn takeover - Nutraceutical Business Review

Click here to get full coverage on ‘Lupin’ Part 4 Gets Premiere Window At Netflix - Deadline

‘Lupin’ Part 4 Gets Premiere Window At Netflix  Deadline

‘Lupin’ Part 4 Gets Premiere Window At Netflix - Deadline

Click here to get full coverage on Kaden joins accounting firm Smolin Lupin as managing director in forensic and valuation services - ROI-NJ

Kaden joins accounting firm Smolin Lupin as managing director in forensic and valuation services  ROI-NJ

Kaden joins accounting firm Smolin Lupin as managing director in forensic and valuation services - ROI-NJ

Click here to get full coverage on Lupin the Third Anime Composer Yuji Ohno Passes Away at 84 - Crunchyroll

Lupin the Third Anime Composer Yuji Ohno Passes Away at 84  Crunchyroll

Lupin the Third Anime Composer Yuji Ohno Passes Away at 84 - Crunchyroll

Click here to get full coverage on Lupin Receives Tentative Approval from U.S. FDA for Sugammadex Injection - Lupin | Press Release - lupin.com

Lupin Receives Tentative Approval from U.S. FDA for Sugammadex Injection - Lupin | Press Release  lupin.com

Lupin Receives Tentative Approval from U.S. FDA for Sugammadex Injection - Lupin | Press Release - lupin.com

Click here to get full coverage on Lupin Receives European Commission Approval for Biosimilar Ranibizumab - Lupin | Press Release - lupin.com

Lupin Receives European Commission Approval for Biosimilar Ranibizumab - Lupin | Press Release  lupin.com

Lupin Receives European Commission Approval for Biosimilar Ranibizumab - Lupin | Press Release - lupin.com

Click here to get full coverage on Lupin eyes US growth through targeted drug launches - CNBC

Lupin eyes US growth through targeted drug launches  CNBC

Lupin eyes US growth through targeted drug launches - CNBC

Click here to get full coverage on A falconry experience at Lupin Lodge - Los Gatan

A falconry experience at Lupin Lodge  Los Gatan

A falconry experience at Lupin Lodge - Los Gatan

Click here to get full coverage on Lupin Signs License and Supply Agreement with Spektus to Commercialize Novel Antidepressant DeslaFlex™ in Canada - Lupin | Press Release - lupin.com

Lupin Signs License and Supply Agreement with Spektus to Commercialize Novel Antidepressant DeslaFlex™ in Canada - Lupin | Press Release  lupin.com

Lupin Signs License and Supply Agreement with Spektus to Commercialize Novel Antidepressant DeslaFlex™ in Canada - Lupin | Press Release - lupin.com

Click here to get full coverage on Lupin Announces Approval of Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets in the United States - Yahoo Finance

Lupin Announces Approval of Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets in the United States  Yahoo Finance

Lupin Announces Approval of Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets in the United States - Yahoo Finance

Click here to get full coverage on LUPIN Outlook for the Week (June 22, 2026 – June 26, 2026) - Equitypandit

LUPIN Outlook for the Week (June 22, 2026 – June 26, 2026)  Equitypandit

LUPIN Outlook for the Week (June 22, 2026 – June 26, 2026) - Equitypandit

Click here to get full coverage on Sandoz will license Lupin's ranibizumab biosimilar in Europe, other select regions - Ophthalmology Times Europe

Sandoz will license Lupin's ranibizumab biosimilar in Europe, other select regions  Ophthalmology Times Europe

Sandoz will license Lupin's ranibizumab biosimilar in Europe, other select regions - Ophthalmology Times Europe

Click here to get full coverage on Takeshi Koike Talks ‘Lupin the Third’ - Animation World Network

Takeshi Koike Talks ‘Lupin the Third’  Animation World Network

LUPIN

Price Chart

Key Statistics

Technicals

About LUPIN

Latest News

'Lupin' Season 4 to Release in October on Netflix - The Hollywood Reporter

Netflix Unveils ‘Lupin’ Part 4 2026 Premiere Date and Poster - Deadline

Lupin Launches Azilsartan Medoxomil Tablets in the United States - PR Newswire

Advanced Charts

Top Gainers

Top Losers